CERS CERUS CORP
Nasdaq · SEC CIK 1020214 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $3.34M 20 sales by 6 insiders
- Filings on record
- 163 since 2021-08-05, latest 2026-08-17 20:18
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Greenman William Mariner | Pres, CEO, Dir | — | $1.20M |
| Benjamin Richard J | Chief Medical Off | — | $670.6K |
| Jayaraman Vivek K | COO | — | $620.1K |
| Green Kevin Dennis | CFO | — | $480.5K |
| Jensen Chrystal | CLO | — | $316.6K |
| BJERKHOLT ERIC | Dir | — | $53.2K |
| Gregory Dean A. | Dir | — | — |
| Shan Hua | Dir | — | — |
| Lucena Ann | Dir | — | — |
| Witney Frank | Dir | — | — |
Transactions 208
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-14 | 2024-03-12 | CERS | Benjamin Richard J | Chief Medical Off | M - OptEx | — | +16.7K | 494.7K | +3% | — |
| DM | 2024-03-14 | 2024-03-13+ | CERS | Benjamin Richard J | Chief Medical Off | S - Sale+OE | $2.01 | -35.1K | 477.4K | -7% | -$70.7K |
| D | 2024-03-14 | 2024-03-12 | CERS | Moore Carol | SVP Reg, Quality | M - OptEx | — | +11.7K | 511.2K | +2% | — |
| DM | 2024-03-14 | 2024-03-13 | CERS | Moore Carol | SVP Reg, Quality | S - Sale+OE | $2.01 | -20.6K | 501.0K | -4% | -$41.5K |
| DM | 2024-03-14 | 2024-03-13+ | CERS | Jayaraman Vivek K | COO | S - Sale+OE | $2.01 | -53.0K | 905.4K | -6% | -$106.9K |
| D | 2024-03-14 | 2024-03-12 | CERS | Jayaraman Vivek K | COO | M - OptEx | — | +25.0K | 931.7K | +3% | — |
| D | 2024-03-14 | 2024-03-12 | CERS | Greenman William Mariner | Pres, CEO, Dir | M - OptEx | — | +64.7K | 3.31M | +2% | — |
| DM | 2024-03-14 | 2024-03-13+ | CERS | Greenman William Mariner | Pres, CEO, Dir | S - Sale+OE | $2.04 | -125.9K | 3.18M | -4% | -$256.9K |
| D | 2024-03-14 | 2024-03-12 | CERS | Jensen Chrystal | CLO | M - OptEx | — | +16.7K | 526.2K | +3% | — |
| DM | 2024-03-14 | 2024-03-13+ | CERS | Jensen Chrystal | CLO | S - Sale+OE | $2.01 | -35.3K | 508.7K | -6% | -$71.1K |
| 2024-03-12 | 2024-03-08 | CERS | Benjamin Richard J | Chief Medical Off | S - Sale | $2.40 | -29.4K | 478.1K | -6% | -$70.5K | |
| 2024-03-05 | 2024-03-01 | CERS | Green Kevin Dennis | CFO | A - Grant | $0.00 | +200.0K | 639.6K | +45% | $0 | |
| 2024-03-05 | 2024-03-01 | CERS | Benjamin Richard J | Chief Medical Off | A - Grant | $0.00 | +160.0K | 507.4K | +46% | $0 | |
| 2024-03-05 | 2024-03-01 | CERS | CORASH LAURENCE M | CSO | A - Grant | $0.00 | +90.0K | 2.35M | +4% | $0 | |
| 2024-03-05 | 2024-03-01 | CERS | Greenman William Mariner | Pres, CEO, Dir | A - Grant | $0.00 | +575.0K | 3.24M | +22% | $0 | |
| 2024-03-05 | 2024-03-01 | CERS | Menard Chrystal | CLO | A - Grant | $0.00 | +160.0K | 509.5K | +46% | $0 | |
| 2024-03-05 | 2024-03-01 | CERS | Moore Carol | SVP Reg, Quality | A - Grant | $0.00 | +75.0K | 499.6K | +18% | $0 | |
| 2024-03-05 | 2024-03-01 | CERS | Jayaraman Vivek K | COO | A - Grant | $0.00 | +240.0K | 906.7K | +36% | $0 | |
| 2023-12-13 | 2023-12-13 | CERS | BJERKHOLT ERIC | Dir | P - Purchase | $1.62 | +10.0K | 142.1K | +8% | +$16.2K | |
| 2023-08-23 | 2023-08-21 | CERS | BJERKHOLT ERIC | Dir | P - Purchase | $1.72 | +10.0K | 132.1K | +8% | +$17.2K | |
| 2023-08-23 | 2023-08-22 | CERS | Lucena Ann | Dir | P - Purchase | $1.69 | +7,500 | 72.3K | +12% | +$12.7K | |
| 2023-06-09 | 2023-06-07 | CERS | MOORE TIMOTHY L. | Dir | A - Grant | $5.00 | +40.0K | 105.1K | +61% | +$200.0K | |
| 2023-06-09 | 2023-06-07 | CERS | SCHULZE GAIL | Dir | A - Grant | $5.00 | +40.0K | 123.4K | +48% | +$200.0K | |
| 2023-06-09 | 2023-06-07 | CERS | BJERKHOLT ERIC | Dir | A - Grant | $5.00 | +40.0K | 122.1K | +49% | +$200.0K | |
| 2023-06-09 | 2023-06-07 | CERS | NACHTSHEIM JAMI K | Dir | A - Grant | $5.00 | +40.0K | 106.4K | +60% | +$200.0K | |
| 2023-06-09 | 2023-06-07 | CERS | Lucena Ann | Dir | A - Grant | $5.00 | +40.0K | 64.8K | +161% | +$200.0K | |
| 2023-06-09 | 2023-06-07 | CERS | Swisher Daniel N JR | Dir | A - Grant | $5.00 | +40.0K | 104.5K | +62% | +$200.0K | |
| 2023-06-09 | 2023-06-07 | CERS | Witney Frank | Dir | A - Grant | $5.00 | +40.0K | 160.1K | +33% | +$200.0K | |
| 2023-05-30 | 2023-05-26 | CERS | Swisher Daniel N JR | Dir | P - Purchase | $1.91 | +5,000 | 118.8K | +4% | +$9,550 | |
| 2023-05-24 | 2023-05-24 | CERS | SCHULZE GAIL | Dir | P - Purchase | $2.03 | +9,850 | 83.4K | +13% | +$20.0K | |
| 2023-05-23 | 2023-05-23 | CERS | BJERKHOLT ERIC | Dir | P - Purchase | $2.00 | +5,000 | 82.1K | +6% | +$10.0K | |
| DM | 2023-03-14 | 2023-03-13 | CERS | Green Kevin Dennis | CFO | S - Sale+OE | $2.80 | -17.2K | 421.8K | -4% | -$48.1K |
| DM | 2023-03-14 | 2023-03-12 | CERS | Green Kevin Dennis | CFO | M - OptEx | — | +45.1K | 431.5K | +12% | — |
| DM | 2023-03-14 | 2023-03-12 | CERS | Menard Chrystal | CLO | M - OptEx | — | +40.1K | 355.3K | +13% | — |
| DM | 2023-03-14 | 2023-03-13 | CERS | Menard Chrystal | CLO | S - Sale+OE | $2.80 | -15.5K | 338.6K | -4% | -$43.3K |
| DM | 2023-03-14 | 2023-03-12 | CERS | CORASH LAURENCE M | CSO | M - OptEx | — | +40.1K | 2.27M | +2% | — |
| DM | 2023-03-14 | 2023-03-13 | CERS | CORASH LAURENCE M | CSO | S - Sale+OE | $2.80 | -15.3K | 2.26M | -0.7% | -$43.0K |
| DM | 2023-03-14 | 2023-03-12 | CERS | Jayaraman Vivek K | COO | M - OptEx | — | +69.2K | 666.9K | +12% | — |
| DM | 2023-03-14 | 2023-03-13 | CERS | Jayaraman Vivek K | COO | S - Sale+OE | $2.80 | -25.4K | 641.9K | -4% | -$71.0K |
| DM | 2023-03-14 | 2023-03-12 | CERS | Benjamin Richard J | Chief Medical Off | M - OptEx | — | +40.1K | 363.2K | +12% | — |
| DM | 2023-03-14 | 2023-03-13 | CERS | Benjamin Richard J | Chief Medical Off | S - Sale+OE | $2.79 | -25.4K | 347.4K | -7% | -$70.8K |
| DM | 2023-03-14 | 2023-03-12 | CERS | Moore Carol | SVP Reg, Quality | M - OptEx | — | +35.1K | 417.3K | +9% | — |
| DM | 2023-03-14 | 2023-03-13 | CERS | Moore Carol | SVP Reg, Quality | S - Sale+OE | $2.80 | -13.1K | 415.9K | -3% | -$36.6K |
| DM | 2023-03-14 | 2023-03-12 | CERS | Greenman William Mariner | Pres, CEO, Dir | M - OptEx | — | +172.2K | 2.68M | +7% | — |
| DM | 2023-03-14 | 2023-03-13 | CERS | Greenman William Mariner | Pres, CEO, Dir | S - Sale+OE | $2.80 | -60.5K | 2.62M | -2% | -$169.3K |
| 2023-03-03 | 2023-03-01 | CERS | Benjamin Richard J | Chief Medical Off | A - Grant | $0.00 | +160.0K | 332.7K | +93% | $0 | |
| 2023-03-03 | 2023-03-01 | CERS | Menard Chrystal | CLO | A - Grant | $0.00 | +160.0K | 324.9K | +97% | $0 | |
| 2023-03-03 | 2023-03-01 | CERS | Jayaraman Vivek K | COO | A - Grant | $0.00 | +240.0K | 614.2K | +64% | $0 | |
| 2023-03-03 | 2023-03-01 | CERS | CORASH LAURENCE M | CSO | A - Grant | $0.00 | +110.0K | 2.24M | +5% | $0 | |
| 2023-03-03 | 2023-03-01 | CERS | Green Kevin Dennis | CFO | A - Grant | $0.00 | +185.0K | 408.0K | +83% | $0 | |
| 2023-03-03 | 2023-03-01 | CERS | Greenman William Mariner | Pres, CEO, Dir | A - Grant | $0.00 | +575.0K | 2.55M | +29% | $0 | |
| 2023-03-03 | 2023-03-01 | CERS | Moore Carol | SVP Reg, Quality | A - Grant | $0.00 | +110.0K | 393.9K | +39% | $0 | |
| DA | 2023-01-03 | 2022-12-28 | CERS | SCHULZE GAIL | Dir | M - OptEx | $3.19 | +25.0K | 73.6K | +51% | +$79.8K |
| D | 2022-12-30 | 2021-12-28 | CERS | SCHULZE GAIL | Dir | M - OptEx | $3.19 | +25.0K | 73.6K | +51% | +$79.8K |
| D | 2022-11-14 | 2022-11-10 | CERS | Swisher Daniel N JR | Dir | S - Sale+OE | $3.91 | -12.5K | 113.8K | -10% | -$48.9K |
| D | 2022-11-14 | 2022-11-10 | CERS | Swisher Daniel N JR | Dir | M - OptEx | $3.19 | +12.5K | 126.3K | +11% | +$39.9K |
| 2022-08-17 | 2022-08-15 | CERS | Menard Chrystal | CLO | S - Sale | $5.18 | -10.0K | 164.9K | -6% | -$51.8K | |
| 2022-08-11 | 2022-08-09 | CERS | Benjamin Richard J | Chief Medical Off | S - Sale | $5.12 | -10.0K | 172.7K | -5% | -$51.2K | |
| D | 2022-07-12 | 2022-07-01 | CERS | Shan Hua | Dir | A - Grant | $0.00 | +29.9K | 29.9K | New | $0 |
| D | 2022-06-03 | 2022-06-01 | CERS | SCHULZE GAIL | Dir | A - Grant | $0.00 | +20.5K | 48.6K | +73% | $0 |
| D | 2022-06-03 | 2022-06-01 | CERS | BJERKHOLT ERIC | Dir | A - Grant | $0.00 | +20.5K | 77.1K | +36% | $0 |
| D | 2022-06-03 | 2022-06-01 | CERS | MOORE TIMOTHY L. | Dir | A - Grant | $0.00 | +20.5K | 65.1K | +46% | $0 |
| D | 2022-06-03 | 2022-06-01 | CERS | NACHTSHEIM JAMI K | Dir | A - Grant | $0.00 | +20.5K | 66.4K | +45% | $0 |
| D | 2022-06-03 | 2022-06-01 | CERS | Swisher Daniel N JR | Dir | A - Grant | $0.00 | +20.5K | 113.8K | +22% | $0 |
| D | 2022-06-03 | 2022-06-01 | CERS | Witney Frank | Dir | A - Grant | $0.00 | +20.5K | 120.1K | +21% | $0 |
| 2022-05-12 | 2022-05-10 | CERS | Green Kevin Dennis | CFO | S - Sale | $4.98 | -57.3K | 223.0K | -20% | -$285.5K | |
| DM | 2022-03-16 | 2022-03-12 | CERS | Moore Carol | SVP Reg, Quality | M - OptEx | — | +79.4K | 273.3K | +41% | — |
| DM | 2022-03-16 | 2022-03-14 | CERS | Moore Carol | SVP Reg, Quality | S - Sale+OE | $5.04 | -28.5K | 271.8K | -9% | -$143.7K |
| DM | 2022-03-16 | 2022-03-14 | CERS | Menard Chrystal | CLO | S - Sale+OE | $5.04 | -30.3K | 164.2K | -16% | -$152.7K |
| DM | 2022-03-16 | 2022-03-12 | CERS | Menard Chrystal | CLO | M - OptEx | — | +84.4K | 180.9K | +88% | — |
| DM | 2022-03-15 | 2022-03-12 | CERS | Benjamin Richard J | Chief Medical Off | M - OptEx | — | +84.4K | 173.5K | +95% | — |
| DM | 2022-03-15 | 2022-03-14 | CERS | Benjamin Richard J | Chief Medical Off | S - Sale+OE | $5.04 | -30.3K | 157.4K | -16% | -$152.7K |
| DM | 2022-03-15 | 2022-03-12 | CERS | Jayaraman Vivek K | COO | M - OptEx | — | +112.9K | 379.6K | +42% | — |
| DM | 2022-03-15 | 2022-03-14 | CERS | Jayaraman Vivek K | COO | S - Sale+OE | $5.04 | -41.7K | 327.1K | -11% | -$210.3K |
| DM | 2022-03-15 | 2022-03-12 | CERS | Greenman William Mariner | Pres, CEO, Dir | M - OptEx | — | +320.7K | 1.99M | +19% | — |
| DM | 2022-03-15 | 2022-03-14 | CERS | Greenman William Mariner | Pres, CEO, Dir | S - Sale+OE | $5.04 | -165.0K | 1.89M | -8% | -$831.7K |
| DM | 2022-03-15 | 2022-03-14 | CERS | CORASH LAURENCE M | CSO | S - Sale+OE | $5.04 | -30.3K | 2.12M | -1% | -$152.7K |
| DM | 2022-03-15 | 2022-03-12 | CERS | CORASH LAURENCE M | CSO | M - OptEx | — | +84.4K | 2.13M | +4% | — |
| DM | 2022-03-15 | 2022-03-12 | CERS | Green Kevin Dennis | CFO | M - OptEx | — | +89.4K | 274.6K | +48% | — |
| DM | 2022-03-15 | 2022-03-14 | CERS | Green Kevin Dennis | CFO | S - Sale+OE | $5.04 | -32.1K | 280.3K | -10% | -$161.8K |
| D | 2022-03-08 | 2022-03-04 | CERS | NACHTSHEIM JAMI K | Dir | M - OptEx | — | +5,127 | 45.9K | +13% | — |
| D | 2022-03-03 | 2022-03-01 | CERS | Moore Carol | SVP Reg, Quality | A - Grant | $0.00 | +45.0K | 228.3K | +25% | $0 |
| D | 2022-03-03 | 2022-03-01 | CERS | CORASH LAURENCE M | CSO | A - Grant | $0.00 | +45.0K | 2.07M | +2% | $0 |
| D | 2022-03-03 | 2022-03-01 | CERS | Benjamin Richard J | Chief Medical Off | A - Grant | $0.00 | +52.5K | 128.5K | +69% | $0 |
| D | 2022-03-03 | 2022-03-01 | CERS | Jayaraman Vivek K | COO | A - Grant | $0.00 | +90.0K | 298.2K | +43% | $0 |
| D | 2022-03-03 | 2022-03-01 | CERS | Menard Chrystal | CLO | A - Grant | $0.00 | +52.5K | 120.7K | +77% | $0 |
| D | 2022-03-03 | 2022-03-01 | CERS | Green Kevin Dennis | CFO | A - Grant | $0.00 | +70.0K | 223.0K | +46% | $0 |
| DM | 2022-03-01 | 2022-02-25 | CERS | Greenman William Mariner | Pres, CEO, Dir | S - Sale+OE | $5.70 | -308.3K | 1.69M | -15% | -$1.76M |
| D | 2022-03-01 | 2022-03-01 | CERS | Greenman William Mariner | Pres, CEO, Dir | A - Grant | $0.00 | +217.5K | 1.81M | +14% | $0 |
| D | 2022-03-01 | 2022-02-25 | CERS | Greenman William Mariner | Pres, CEO, Dir | M - OptEx | $3.75 | +380.0K | 1.90M | +25% | +$1.43M |
| D | 2022-01-05 | 2022-01-03 | CERS | Moore Carol | SVP Reg, Quality | M - OptEx | $3.66 | +19.1K | 200.3K | +11% | +$69.8K |
| D | 2022-01-05 | 2022-01-03 | CERS | Moore Carol | SVP Reg, Quality | S - Sale+OE | $7.00 | -19.1K | 181.3K | -10% | -$133.4K |
| D | 2021-12-21 | 2021-12-17 | CERS | CORASH LAURENCE M | CSO | M - OptEx | $3.75 | +5,000 | 2.03M | +0.2% | +$18.8K |
| D | 2021-12-15 | 2021-12-13 | CERS | CORASH LAURENCE M | CSO | M - OptEx | $3.75 | +40.0K | 2.02M | +2% | +$150.0K |
| D | 2021-11-09 | 2021-11-09 | CERS | SCHULZE GAIL | Dir | M - OptEx | $2.86 | +25.0K | 53.1K | +89% | +$71.5K |
| D | 2021-11-09 | 2021-11-09 | CERS | SCHULZE GAIL | Dir | S - Sale+OE | $7.54 | -25.0K | 28.1K | -47% | -$188.5K |
| D | 2021-11-09 | 2021-11-05 | CERS | Moore Carol | SVP Reg, Quality | S - Sale+OE | $7.94 | -110.0K | 181.3K | -38% | -$873.4K |
| D | 2021-11-09 | 2021-11-05 | CERS | Moore Carol | SVP Reg, Quality | M - OptEx | $3.75 | +110.0K | 289.6K | +61% | +$412.5K |
| 2021-11-05 | 2021-11-03 | CERS | Menard Chrystal | CLO | S - Sale | $7.70 | -40.0K | 67.0K | -37% | -$308.0K | |
| DM | 2021-11-05 | 2021-11-03 | CERS | Benjamin Richard J | Chief Medical Off | M - OptEx | $4.56 | +165.0K | 109.4K | New | +$753.1K |
Purchase Sale Sale after option exercise All abbreviations